Could Nef and Vpr proteins contribute to disease progression by promoting depletion of bystander cells and prolonged survival of HIV-infected cells?

被引:57
作者
Azad, AA [1 ]
机构
[1] Biomol Res Inst, Parkville, Vic 3052, Australia
关键词
HIV; AIDS; Nef; Vpr; cytopathicity; cytotoxicity; apoptosis;
D O I
10.1006/bbrc.1999.1708
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A growing body of literature suggests that the HIV accessory proteins Nef and Vpr could be involved in depletion of CD4(+) and non-CD4(+) cells and tissue atrophy, and in delaying the death of HIV-infected cells. Cell depletion is likely to be predominantly a bystander effect because the number of cells dying far outnumbers HIV-infected cells and is not confined to CD4(+) cells. The myristylated N-terminal region of Nef has severe membrane disordering properties, and when present in the extracellular medium causes rapid lysis in vitro of a wide range of CD4(+) and non-CD4(+) cells, suggesting a role for extracellular Nef in the depletion of bystander cells. A direct role for HIV-1 Nef in cytopathicity is supported by studies in HIV-infected Bu Liv/Thy SCID mice, in transgenic mice expressing nef gene alone, and in rhesus macaques infected with SIV/HIV chimeric virus containing HTV-1 nef: The N-terminal region of Nef has been directly implicated in development of simian AIDS. Extracellular Vpr and C-terminal fragments of Vpr cause membrane permeabilization and apoptosis of a wide range of CD4(+) and non-CD4(+) cells, and could also contribute to depletion of bystander cells. A direct in vivo role for Vpr in thymocyte depletion, thymic atrophy, and nephropathy is suggested in studies with vpr transgenic mice. Intracellular Nef and Vpr could help HIV-infected cells evade cell death by inhibiting apoptosis of infected cells and by avoiding virus-specific CTL response. Nef and Vpr are potential targets for therapeutic intervention and vaccine development, and strategies that prevent the death of bystander cells while promoting the early death of HIV-infected cells could arrest or retard progression to AIDS. (C) 2000 Academic Press.
引用
收藏
页码:677 / 685
页数:9
相关论文
共 139 条
[91]   Extracellular addition of a domain of HIV-1 Vpr containing the amino acid sequence motif H(S/F)RIG causes cell membrane permeabilization and death [J].
Macreadie, IG ;
Arunagiri, CK ;
Hewish, DR ;
White, JF ;
Azad, AA .
MOLECULAR MICROBIOLOGY, 1996, 19 (06) :1185-1192
[92]   STRESS-DEPENDENT AND SEQUENCE-DEPENDENT RELEASE INTO THE CULTURE-MEDIUM OF HIV-1 NEF PRODUCED IN SACCHAROMYCES-CEREVISIAE [J].
MACREADIE, IG ;
CASTELLI, LA ;
LUCANTONI, A ;
AZAD, AA .
GENE, 1995, 162 (02) :239-243
[93]   Expression of HIV-1 nef in yeast causes membrane perturbation and release of the myristylated Nef protein [J].
Macreadie, IG ;
Fernley, R ;
Castelli, LA ;
Lucantoni, A ;
White, J ;
Azad, A .
JOURNAL OF BIOMEDICAL SCIENCE, 1998, 5 (03) :203-210
[94]   Cytotoxicity resulting from addition of HIV-1 Nef N-terminal peptides to yeast and bacterial cells [J].
Macreadie, IG ;
Lowe, MG ;
Curtain, CC ;
Hewish, D ;
Azad, AA .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1997, 232 (03) :707-711
[95]   HIV-1 protein Vpr causes gross mitochondrial dysfunction in the yeast Saccharomyces cerevisiae [J].
Macreadie, IG ;
Thorburn, DR ;
Kirby, DM ;
Castelli, LA ;
deRozario, NL ;
Azad, AA .
FEBS LETTERS, 1997, 410 (2-3) :145-149
[96]  
MANDELL CP, 1999, KEYST S AIDS PATH JA
[97]   Nef-induced CD4 and major histocompatibility complex class I (MHC-I) down-regulation are governed by distinct determinants: N-terminal alpha helix and proline repeat of Nef selectively regulate MHC-I trafficking [J].
Mangasarian, A ;
Piguet, V ;
Wang, JK ;
Chen, YL ;
Trono, D .
JOURNAL OF VIROLOGY, 1999, 73 (03) :1964-1973
[98]   A VIRION-SPECIFIC INHIBITORY MOLECULE WITH THERAPEUTIC POTENTIAL FOR HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 [J].
MATSUDA, Z ;
YU, XF ;
YU, QC ;
LEE, TH ;
ESSEX, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (08) :3544-3548
[99]   T-CELL DYSFUNCTION IN HIV-INFECTION - ANERGY DUE TO DEFECTIVE ANTIGEN-PRESENTING CELL-FUNCTION [J].
MEYAARD, L ;
SCHUITEMAKER, H ;
MIEDEMA, F .
IMMUNOLOGY TODAY, 1993, 14 (04) :161-164
[100]  
MUROCACHO CA, 1995, J IMMUNOL, V154, P5555